Katie Chow
Papers
1
Total Citations
42
H-Index
1
About
Dr. Katie Chow is a leading figure in the field of precision oncology and molecular diagnostics, with a primary focus on hereditary cancer syndromes. Her most impactful work centers on the development and clinical validation of next-generation sequencing assays for detecting germline mutations in the *BRCA1* and *BRCA2* genes. Her landmark 2013 study, which has garnered 42 citations, introduced a clinically validated second-generation sequencing assay that dramatically improved the accuracy, speed, and accessibility of hereditary breast and ovarian cancer risk assessment. This contribution has been instrumental in transitioning *BRCA* testing from costly, time-consuming methods to a streamlined, clinically actionable tool. By establishing rigorous validation protocols, Dr. Chow’s work has set a benchmark for diagnostic sequencing, directly enabling earlier interventions and personalized treatment strategies for at-risk patients. Her research bridges the gap between genomic technology and bedside care, making her a pivotal figure in the integration of molecular diagnostics into routine oncology practice.
Research Focus
Key Achievements
Top Papers
- 1